ROSA AGUERO: Open Payments
NPI 1215534888 · WHITTIER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,057 in 20 payments from 7 companies in 2025. Trend: 2023 $791 · 2024 $285 · 2025 $2,057
Food & beverage: $1,981Education: $76
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $806 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $400 |
| Teva Pharmaceuticals USA, Inc. | 3 | $287 |
| E.R. Squibb & Sons, L.L.C. | 2 | $254 |
| Alkermes, Inc. | 1 | $130 |
| Supernus Pharmaceuticals, Inc. | 1 | $124 |
| Axsome Therapeutics, Inc. | 2 | $56 |
Products named: INVEGA SUSTENNA, CAPLYTA, COBENFY, AUSTEDO XR, LYBALVI, Qelbree, Auvelity.
Industry payments across CA — which companies pay providers there.
